| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Roux S | |
| Orcel P | |||
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 | ||
| Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis | Q24324701 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
| Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures | Q33636797 | ||
| The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | Q33823576 | ||
| Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction | Q33886695 | ||
| Interleukin-11: a new cytokine critical for osteoclast development | Q34138407 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors | Q35824058 | ||
| Modulation of osteoclast differentiation | Q35957509 | ||
| Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells | Q37295785 | ||
| Bone cytokines | Q40917596 | ||
| Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells | Q40927574 | ||
| Transforming growth factor-beta enhances calcitonin-induced cyclic AMP production and the number of calcitonin receptors in long-term cultures of human umbilical cord blood monocytes in the presence of 1,25-dihydroxycholecalciferol | Q41606994 | ||
| A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. | Q41687961 | ||
| Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. | Q51124042 | ||
| Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. | Q51670417 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. | Q53768934 | ||
| Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells. | Q54202809 | ||
| Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts. | Q54323821 | ||
| Osteoblastic cells are involved in osteoclast formation. | Q54374668 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Effects of transforming growth factor-? on long-term human cord blood monocyte cultures | Q67654096 | ||
| Interleukin-6: an osteotropic factor? | Q68178962 | ||
| Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism | Q68184883 | ||
| Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro | Q69738552 | ||
| Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype | Q70160072 | ||
| Cytokines and anti-cytokines | Q70598188 | ||
| Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone | Q71556981 | ||
| Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes | Q72401339 | ||
| Activated T lymphocytes support osteoclast formation in vitro | Q73149439 | ||
| Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro | Q73344825 | ||
| Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor | Q73490934 | ||
| Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis | Q73490940 | ||
| A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro | Q77342999 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| osteoporosis | Q165328 | ||
| cell differentiation | Q210861 | ||
| P304 | page(s) | 451-456 | |
| P577 | publication date | 2000-09-06 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| Arthritis Research | Q45128333 | ||
| P1476 | title | Bone loss. Factors that regulate osteoclast differentiation: an update | |
| P478 | volume | 2 |
| Q34999751 | A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation |
| Q46864205 | A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model |
| Q37195476 | Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis |
| Q36067491 | Adenosine A2A receptor activation prevents wear particle-induced osteolysis |
| Q35755292 | Antigens of bacteria associated with periodontitis. |
| Q35629551 | Aseptic loosening |
| Q45062371 | Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids |
| Q36165341 | Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants |
| Q40963795 | Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation |
| Q37298394 | Ectopic osteogenesis and angiogenesis regulated by porous architecture of hydroxyapatite scaffolds with similar interconnecting structure in vivo |
| Q51063954 | Effect of simvastatin on kinetics of osteoprotegrin/receptor activator nuclear kappa B Ligand mRNA expression in periapical lesions. |
| Q39680232 | Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis. |
| Q53702255 | Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis. |
| Q36224872 | Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line |
| Q90452562 | Eimeria challenge adversely affected long bone attributes linked to increased resorption in 14-day-old broiler chickens |
| Q40610387 | Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity |
| Q37886401 | Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review |
| Q46145950 | Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways |
| Q46440419 | Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro |
| Q47608070 | Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status. |
| Q92801327 | Maintained Properties of Aged Dental Pulp Stem Cells for Superior Periodontal Tissue Regeneration |
| Q22242347 | Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease |
| Q35084886 | Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB |
| Q28343869 | Nitric oxide and bone |
| Q36703987 | Novel host response therapeutic approaches to treat periodontal diseases. |
| Q38956740 | Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission |
| Q35612713 | Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report |
| Q46504216 | Palm tocotrienol exerted better antioxidant activities in bone than alpha-tocopherol. |
| Q61480355 | Prenatal Exposure to IL-1β Results in Disturbed Skeletal Growth in Adult Rat Offspring |
| Q35552836 | Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis |
| Q39316805 | Revisiting the role of testosterone: Are we missing something? |
| Q38930778 | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway |
| Q61808707 | Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption |
| Q36235672 | Sustained mitogen-activated protein kinase activation with Aggregatibacter actinomycetemcomitans causes inflammatory bone loss |
| Q35124114 | Teasing apart the complex genetics of human autoimmunity: lessons from rheumatoid arthritis |
| Q58919601 | Teratogenic Effects of Crude Ethanolic Root Bark and Leaf Extracts ofRauwolfia vomitoria(Apocynaceae) on the Femur of Albino Wistar Rat Fetuses |
| Q53526456 | The association of osteoprotegerin gene polymorphisms with periodontitis. |
| Q33360030 | The synovio-entheseal complex in enthesoarthritis |
| Q64105473 | Understanding Peri-Implantitis as a Plaque-Associated and Site-Specific Entity: On the Local Predisposing Factors |
| Q36355362 | Vitamin e and bone structural changes: an evidence-based review |
| Q80953240 | [Corticosteroid-induced osteoporosis] |
| Q44239401 | iNOS-derived nitric oxide modulates infection-stimulated bone loss. |
Search more.